other material
confidence high
sentiment negative
materiality 0.60
Cingulate closes $7.5M public offering of common stock and warrants
Cingulate Inc.
- Gross proceeds $7.5M; net ~$6.5M after fees. Offering: 3.75M shares (or pre-funded warrants) plus Series A and B warrants.
- Each unit priced at $2.00 includes one share (or pre-funded warrant at $1.9999), one Series A warrant ($2.00, 5yr), one Series B warrant ($2.00, 2yr).
- Proceeds to fund R&D and commercialization of lead candidate CTx-1301 and for general corporate purposes.
- H.C. Wainwright acted as placement agent; cash fee 7.8% of gross proceeds, expense allowance, and warrants for 150,000 shares at $2.50.
- Company agreed to 90-day lock on new equity issuances and one-year ban on variable rate transactions.